Skip to main content

UBS Group AG

Position in ADCT — ADC Therapeutics SA

CIK 1610520 ZURICH, V8

Position in ADCT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,720,882
+$961,185 QoQ
Shares Held
458,902
+113.2% QoQ
Ownership
0.361%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

UBS Group AG holds $1,523,036,852 across 81 Drug Manufacturers - Specialty & Generic names. ADCT ranks #38 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADCT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,720,882 458,902
2025-12-31 $759,697 215,212
2025-09-30 $1,049,044 262,261
2025-06-30 $2,217,900 827,575
2025-03-31 $1,081,559 767,064
2024-12-31 $1,760,190 884,518
2024-09-30 $125,290 39,775
2024-06-30 $66,969 21,193
2024-03-31 $228 51
2023-03-31 $22,038 11,302
2022-12-31 $11,197 2,916
2021-12-31 $49,005 2,426
2021-06-30 $3,822 157
2021-03-31 $3,832 157
2020-12-31 $46,894 1,465
2020-09-30 $4,651 141